These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34935257)

  • 1. Pregnancy with inflammatory bowel disease: Outcomes for mothers and their children at a European tertiary care center.
    Hoffmann P; Krueger J; Bashlekova T; Rupp C; Baumann L; Gauss A
    J Obstet Gynaecol Res; 2022 Mar; 48(3):621-633. PubMed ID: 34935257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry.
    Odufalu FD; Long M; Lin K; Mahadevan U;
    Gut; 2022 Sep; 71(9):1766-1772. PubMed ID: 34686575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory bowel disease in pregnancy: a population-based study of prevalence and pregnancy outcomes.
    Shand AW; Chen JS; Selby W; Solomon M; Roberts CL
    BJOG; 2016 Oct; 123(11):1862-70. PubMed ID: 26924786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease.
    Kammerlander H; Nielsen J; Kjeldsen J; Knudsen T; Friedman S; Nørgård B
    Inflamm Bowel Dis; 2017 Jun; 23(6):1011-1018. PubMed ID: 28346274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Thiopurines During Conception and Pregnancy Is Not Associated With Adverse Pregnancy Outcomes or Health of Infants at One Year in a Prospective Study.
    Kanis SL; de Lima-Karagiannis A; de Boer NKH; van der Woude CJ
    Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1232-1241.e1. PubMed ID: 28342949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health outcomes of 1000 children born to mothers with inflammatory bowel disease in their first 5 years of life.
    Kanis SL; Modderman S; Escher JC; Erler N; Beukers R; de Boer N; Bodelier A; Depla ACTM; Dijkstra G; van Dijk ARM; Gilissen L; Hoentjen F; Jansen JM; Kuyvenhoven J; Mahmmod N; Mallant-Hent RC; van der Meulen-de Jong AE; Noruzi A; Oldenburg B; Oostenbrug LE; Ter Borg PCJ; Pierik M; Romberg-Camps M; Thijs W; West R; de Lima A; van der Woude CJ;
    Gut; 2021 Jul; 70(7):1266-1274. PubMed ID: 33046558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study.
    Dominitz JA; Young JC; Boyko EJ
    Am J Gastroenterol; 2002 Mar; 97(3):641-8. PubMed ID: 11926208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Trends in Pregnancy Outcomes Among Women With Inflammatory Bowel Disease in the Era of Biologics: A 20-Year Nationwide Analysis.
    Prakash P; Dua A; Blumenfeld Y; Chen PH; Parian AM; Limketkai BN
    Inflamm Bowel Dis; 2024 Oct; 30(10):1788-1795. PubMed ID: 37857421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.
    de Lima-Karagiannis A; Zelinkova-Detkova Z; van der Woude CJ
    Am J Gastroenterol; 2016 Sep; 111(9):1305-12. PubMed ID: 27349339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study.
    Bortlik M; Machkova N; Duricova D; Malickova K; Hrdlicka L; Lukas M; Kohout P; Shonova O; Lukas M
    Scand J Gastroenterol; 2013 Aug; 48(8):951-8. PubMed ID: 23834232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse birth outcomes and early-life infections after in utero exposure to corticosteroids for inflammatory bowel disease: a Danish nationwide cohort study.
    Jølving LR; Nielsen J; Andersen ML; Friedman S; Nørgård BM
    BMC Med; 2023 Apr; 21(1):140. PubMed ID: 37046314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of azathioprine and corticosteroids during pregnancy and birth outcome in women diagnosed with inflammatory bowel disease.
    Plauborg AV; Hansen AV; Garne E
    Birth Defects Res A Clin Mol Teratol; 2016 Jun; 106(6):494-9. PubMed ID: 27301563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstetric outcomes of patients with inflammatory bowel disease.
    Tondreau A; Breuval C; Gondry J; Fumery M; Foulon A
    Arch Gynecol Obstet; 2024 Aug; 310(2):943-951. PubMed ID: 38834885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab.
    Moens A; van Hoeve K; Humblet E; Rahier JF; Bossuyt P; Dewit S; Franchimont D; Macken E; Nijs J; Posen A; Strubbe B; Van Hootegem A; Van Moerkercke W; Vermeire S; Ferrante M;
    J Crohns Colitis; 2019 Jan; 13(1):12-18. PubMed ID: 30281093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of nitrogen dioxide on low birth weight in women with inflammatory bowel disease: a Norwegian pregnancy cohort study (MoBa).
    Garshol BF; Aamodt G; Madsen C; Vatn MH; Bengtson MB
    Scand J Gastroenterol; 2020 Mar; 55(3):272-278. PubMed ID: 32064969
    [No Abstract]   [Full Text] [Related]  

  • 17. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study.
    Moens A; van der Woude CJ; Julsgaard M; Humblet E; Sheridan J; Baumgart DC; Gilletta De Saint-Joseph C; Nancey S; Rahier JF; Bossuyt P; Cremer A; Dewit S; Eriksson C; Hoentjen F; Krause T; Louis E; Macken E; Milenkovic Z; Nijs J; Posen A; Van Hootegem A; Van Moerkercke W; Vermeire S; Bar-Gil Shitrit A; Ferrante M
    Aliment Pharmacol Ther; 2020 Jan; 51(1):129-138. PubMed ID: 31692017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with inflammatory bowel disease.
    Leung YP; Kaplan GG; Coward S; Tanyingoh D; Kaplan BJ; Johnston DW; Barkema HW; Ghosh S; Panaccione R; Seow CH; ;
    J Crohns Colitis; 2015 Mar; 9(3):223-30. PubMed ID: 25576754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD).
    Shim L; Eslick GD; Simring AA; Murray H; Weltman MD
    J Crohns Colitis; 2011 Jun; 5(3):234-8. PubMed ID: 21575887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy outcomes in women with inflammatory bowel disease who successfully conceived via assisted reproduction technique.
    Lavie I; Lavie M; Doyev R; Fouks Y; Azem F; Yogev Y
    Arch Gynecol Obstet; 2020 Sep; 302(3):611-618. PubMed ID: 32529298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.